Stomach Cancer Astrazeneca Drug
-
{
- All
- News
'Stomach Cancer Astrazeneca Drug' - 1 News Result(s)
-
AstraZeneca's Experimental Stomach Cancer Drug Doubles Survival In Trial
AstraZeneca's experimental antibody-drug conjugate sonesitatug vedotin has doubled overall survival in a late-stage trial for advanced stomach cancer patients, offering renewed hope for hard-to-treat gastric cancers across global populations.
'Stomach Cancer Astrazeneca Drug' - 1 News Result(s)
-
AstraZeneca's Experimental Stomach Cancer Drug Doubles Survival In Trial
AstraZeneca's experimental antibody-drug conjugate sonesitatug vedotin has doubled overall survival in a late-stage trial for advanced stomach cancer patients, offering renewed hope for hard-to-treat gastric cancers across global populations.
